Menu Back to Advanced-Regulatory-Affairs-Training-Course-in-Japan

Program Committee

  • Yomei  Matsuoka, MSc
    Yomei Matsuoka, MSc Senior Director, Safety Evaluation & Planning Group IV, Pharmacovigilance Dept Daiichi Sankyo Co., Ltd., Japan
  • Satoshi  Fukunaga
    Satoshi Fukunaga UCB Japan Co., Ltd., Japan
  • Teruyo  Arato, PhD
    Teruyo Arato, PhD Professor, Department of Regulatory Science Hokkaido University Graduate School of Medicine, Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Director, Vaccine Policy, Health Policy and Access MSD K.K., Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Clinical Research Coordinator St. Luke's International Hospital, Japan
  • Kiyohito  Nakai, PhD
    Kiyohito Nakai, PhD Director, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare, Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, Regulatory Operation & Prescribing Information Group, Drug RA Dept. Novartis Pharma K.K., Japan
  • Norikazu  Takahata
    Norikazu Takahata President Plus Action for Children, Japan
  • Nao  Tsuchida, MD, PhD
    Nao Tsuchida, MD, PhD Chief National Hospital Organization Headquarters, Japan
  • Yoshiaki  Uyama, PhD
    Yoshiaki Uyama, PhD Director, Office of Medical Informatics and Epidemiology Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More